Search

everythinglearnresearchcommunity

for

Search:↓

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Minoxidil can reduce functions related to androgen receptors.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

Caizhixuan hair tonic helps treat hair loss by promoting hair growth and improving hair follicles.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Finasteride affects prostate development differently in male and female Mongolian gerbils.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

A new method effectively predicts estrogen-related health effects for early screening.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.